11096 Federal Register / Vol. 87, No. 39 / Monday, February 28, 2022 / Notices 

terminate the investigation in its 

entirety based on withdrawal of the 

complaint allegations. 

FOR FURTHER INFORMATION CONTACT: 

Michael Liberman, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–2392. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: On March 

8, 2021, the Commission instituted this 

investigation under section 337 of the 

Tariff Act of 1930, as amended, 19 

U.S.C. 1337 (‘‘section 337’’), based on a 

complaint filed by Evolved Wireless, 

LLC of Austin, Texas (‘‘Evolved’’). 86 FR 

13399–400 (Mar. 8, 2021). The 

complaint alleged a violation of section 

337 in the importation into the United 

States, the sale for importation, or the 

sale within the United States after 

importation of certain LTE-compliant 

cellular communication devices by 

reason of infringement of certain claims 

of U.S. Patent Nos. RE46,679; RE48,326 

(‘‘the ’326 patent’’); and 10,517,120 

(‘‘the ’120 patent’’). The complaint also 

alleged the existence of a domestic 

industry. The notice of investigation 

named Samsung Electronics Co., Ltd. of 

Gyeonngi-Do, Republic of Korea; 

Samsung Electronics America, Inc. of 

Ridgefield Park, New Jersey; and 

Motorola Mobility LLC of Chicago, 

Illinois as respondents. Id. at 13400. The 

Commission’s Office of Unfair Import 

Investigations was also named as a party 

in this investigation. Id. Subsequently, 

the Commission terminated all asserted 

claims of the ’120 patent and claims 19 

and 20 of the ’326 patent from the 

investigation by reason of withdrawal of 

the complaint allegations. Order No. 15 

(Aug. 26, 2021), unreviewed by Notice 

(Sep. 24, 2021); Order No. 26 (Dec. 3, 

2021), unreviewed by Notice (Dec. 20, 

2021). 

On January 13, 2022, complainant 

Evolved filed an unopposed motion to 

terminate this investigation by reason of 

withdrawal of complaint allegations 

under Commission Rule 210.21(a), 19 

CFR 210.21(a). On January 19, 2022, the 

Commission investigative attorney filed 

a contingent statement of support of the 

motion. 

On January 31, 2022, the ALJ issued 

the subject ID (Order No. 36) granting 

complainant’s motion. The ID finds that 

there are no extraordinary 

circumstances that would prevent the 

requested termination of this 

investigation. The ID also finds Evolved 

has complied with the requirements of 

Commission Rule 210.21(a). No party 

petitioned for review of the ID. 

The Commission has determined not 

to review the subject ID. The 

investigation is terminated in its 

entirety. 

The Commission vote for this 

determination took place on February 

22, 2022. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended, 19 U.S.C. 1337, and in Part 

210 of the Commission’s Rules of 

Practice and Procedure, 19 CFR part 

210. 

By order of the Commission. 

Issued: February 22, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–04097 Filed 2–25–22; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1239] 

Certain Gabapentin Immunoassay Kits 

and Test Strips, Components Thereof, 

and Methods Therefor; Commission 

Determination Not To Review an Initial 

Determination Terminating a Final 

Respondent Based on Settlement; 

Request for Written Submissions on 

Remedy, the Public Interest, and 

Bonding 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has determined not to 

review an initial determination (‘‘ID’’) 

(Order No. 29) terminating the final, 

non-defaulting respondent, Shanghai 

Chemtron Biotech Co. Ltd., in the 

above-captioned investigation based on 

settlement. The Commission has further 

determined to find that the 

complainants’ declaration seeking 

immediate relief against a respondent 

previously found to be in default is 

moot. The Commission also requests 

written submissions from the parties, 

interested government agencies, and 

interested persons on remedy, the 

public interest, and bonding concerning 

the defaulted respondent. 

FOR FURTHER INFORMATION CONTACT: 

Lynde Herzbach, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3228. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: On 

January 25, 2021, the Commission 

instituted this investigation under 

section 337 of the Tariff Act of 1930, as 

amended, 19 U.S.C. 1337 (‘‘section 

337’’), based on a complaint filed by 

ARK Diagnostics, Inc. of Fremont, 

California (‘‘ARK’’). See 86 FR 6918–19. 

The complaint, as supplemented, 

alleges a violation of section 337 based 

upon the importation into the United 

States, sale for importation, or sale after 

importation into the United States of 

certain gabapentin immunoassay kits 

and test strips, components thereof, and 

methods therefor by reason of 

infringement of certain claims of U.S. 

Patent Nos. 8,828,665 and 10,203,345. 

Id. The complaint further alleges that a 

domestic industry exists. Id. The notice 

of investigation names fourteen 

respondents, including Shanghai 

Chemtron Biotech Co., Ltd. of Shanghai, 

China (‘‘Shanghai Chemtron’’) and 

Kappa City Biotech, SAS of Montlucon, 

France (‘‘Kappa City’’). See id. The 

complaint and notice of investigation 

were later amended to add two 

respondents. Order No. 8 (March 9, 

2021), unreviewed by 86 FR 16640–41 

(March 30, 2021). 

The Commission previously 

terminated six respondents based on 

consent orders. Order Nos. 11 and 12 

(Mar. 31, 2021), unreviewed by Comm’n 

Notice (Apr. 15, 2021); Order No. 14 

(April 9, 2021), unreviewed by Comm’n 

Notice (Apr. 22, 2021); Order No. 15 

(April 12, 2021), unreviewed by Comm’n 

Notice (May 12, 2021). The Commission 

also previously terminated three 

respondents based on settlement 

agreements. Order No. 13 (Apr. 5, 2021), 

unreviewed by Comm’n Notice (Apr. 19, 

2021); Order No. 17 (May 5, 2021), 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 39 / Monday, February 28, 2022 / Notices 11097 

unreviewed by Comm’n Notice (May 18, 

2021); Order No. 18 (May 20, 2021), 

unreviewed by Comm’n Notice (June 21, 

2021). The Commission also terminated 

five respondents based on partial 

withdrawal of the complaint. Order No. 

20 (June 4, 2021), unreviewed by 

Comm’n Notice (June 28, 2021); Order 

No. 21 (June 14, 2021), unreviewed by 

Comm’n Notice (July 1, 2021). 

On May 18, 2021, the Commission 

determined not to review an initial 

determination (Order No. 16) finding 

Kappa City in default. Order No. 16 

(Apr. 30, 2021), unreviewed by Comm’n 

Notice (May 18, 2021). 

On December 7, 2021, ARK filed a 

declaration seeking immediate entry of 

a limited exclusion order and cease and 

desist order against Kappa City. 

On January 20, 2022, ARK filed a 

motion to terminate this investigation 

with respect to Shanghai Chemtron 

based on a settlement. 

On January 31, 2022, the presiding 

administrative law judge issued the 

subject ID granting the motion to 

terminate Shanghai Chemtron based on 

settlement. See Order No. 29 (Jan. 31, 

2022). The subject ID finds that the 

motion complies with Commission Rule 

210.21(b)(1) (19 CFR 210.21(b)) and that 

no extraordinary circumstances prevent 

denying the motion. The subject ID 

further finds that termination of 

Shanghai Chemtron based on settlement 

would not be contrary to the public 

interest. 

No party petitioned for review of the 

subject ID. 

The Commission has determined not 

to review the subject ID (Order No. 29). 

Shanghai Chemtron is terminated from 

the investigation. 

The Commission has further 

determined that ARK’s declaration is 

now moot given the termination of the 

final remaining non-defaulting 

respondent in this investigation. The 

Commission has also determined to 

request briefing on the issues of remedy, 

bonding, and the public interest. 

In connection with the final 

disposition of this investigation, the 

statute authorizes issuance of, inter alia, 

(1) an exclusion order that could result 

in the exclusion of the subject articles 

from entry into the United States; and/ 

or (2) a cease and desist order that could 

result in the respondent being required 

to cease and desist from engaging in 

unfair acts in the importation and sale 

of such articles. Accordingly, the 

Commission is interested in receiving 

written submissions that address the 

form of remedy, if any, that should be 

ordered. If a party seeks exclusion of an 

article from entry into the United States 

for purposes other than entry for 

consumption, the party should so 

indicate and provide information 

establishing that activities involving 

other types of entry either are adversely 

affecting it or likely to do so. For 

background, see Certain Devices for 

Connecting Computers via Telephone 

Lines, Inv. No. 337–TA–360, USITC 

Pub. No. 2843, Comm’n Op. at 7–10 

(Dec. 1994). 

The statute requires the Commission 

to consider the effects of that remedy 

upon the public interest. The public 

interest factors the Commission will 

consider include the effect that an 

exclusion order and cease and desist 

order would have on: (1) The public 

health and welfare, (2) competitive 

conditions in the U.S. economy, (3) U.S. 

production of articles that are like or 

directly competitive with those that are 

subject to investigation, and (4) U.S. 

consumers. The Commission is 

therefore interested in receiving written 

submissions that address the 

aforementioned public interest factors 

in the context of this investigation. 

If the Commission orders some form 

of remedy, the U.S. Trade 

Representative, as delegated by the 

President, has 60 days to approve, 

disapprove, or take no action on the 

Commission’s determination. See 

Presidential Memorandum of July 21, 

2005, 70 FR 43251 (July 26, 2005). 

During this period, the subject articles 

would be entitled to enter the United 

States under bond, in an amount 

determined by the Commission and 

prescribed by the Secretary of the 

Treasury. The Commission is therefore 

interested in receiving submissions 

concerning the amount of the bond that 

should be imposed if a remedy is 

ordered. 

Written Submissions: Parties to the 

investigation, interested government 

agencies, and any other interested 

parties are encouraged to file written 

submissions on the issues of remedy, 

the public interest, and bonding. 

ARK is requested to submit proposed 

remedial orders for the Commission’s 

consideration. ARK is further requested 

to state the dates that the Asserted 

Patents expire, to provide the HTSUS 

subheadings under which the accused 

products are imported, and to supply 

the identification information for all 

known importers of the products at 

issue in this investigation. The initial 

written submissions and proposed 

remedial orders must be filed no later 

than close of business on March 8, 2022. 

Reply submissions must be filed no later 

than the close of business on March 15, 

2022. No further submissions on these 

issues will be permitted unless 

otherwise ordered by the Commission. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. The Commission’s paper 

filing requirements in 19 CFR 210.4(f) 

are currently waived. 85 FR 15798 

(March 19, 2020). Submissions should 

refer to the investigation number (Inv. 

No. 337–TA–1239) in a prominent place 

on the cover page and/or the first page. 

(See Handbook for Electronic Filing 

Procedures, https://www.usitc.gov/ 

documents/handbook_on_filing_

procedures.pdf). Persons with questions 

regarding filing should contact the 

Secretary, (202) 205–2000. 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment by marking each document 

with a header indicating that the 

document contains confidential 

information. This marking will be 

deemed to satisfy the request procedure 

set forth in Rules 201.6(b) and 

210.5(e)(2) (19 CFR 201.6(b) & 

210.5(e)(2)). Documents for which 

confidential treatment by the 

Commission is properly sought will be 

treated accordingly. A redacted nonconfidential version of the document 

must also be filed simultaneously with 

any confidential filing. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel, solely for cybersecurity 

purposes. All contract personnel will 

sign appropriate nondisclosure 

agreements. All nonconfidential written 

submissions will be available for public 

inspection on EDIS. 

The Commission vote for this 

determination took place on February 

22, 2022. 

While temporary remote operating 

procedures are in place in response to 

COVID–19, the Office of the Secretary is 

not able to serve parties that have not 

retained counsel or otherwise provided 

a point of contact for electronic service. 

Accordingly, pursuant to Commission 

Rules 201.16(a) and 210.7(a)(1) (19 CFR 

201.16(a), 210.7(a)(1)), the Commission 

orders that the complainant complete 

service for any party/parties without a 


khammond on DSKJM1Z7X2PROD with NOTICES
11098 Federal Register / Vol. 87, No. 39 / Monday, February 28, 2022 / Notices 

method of electronic service noted on 

the attached Certificate of Service and 

shall file proof of service on the 

Electronic Document Information 

System (EDIS). 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in Part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: February 22, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–04080 Filed 2–25–22; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1110–0009] 

Agency Information Collection 

Activities; Proposed eCollection; 

eComments Requested: Law 

Enforcement Officers Killed and 

Assaulted Program, Analysis of 

Officers Feloniously Killed and 

Assaulted; and Law Enforcement 

Officers Killed and Assaulted Program; 

Analysis of Officers Accidentally Killed 

AGENCY: Federal Bureau of 

Investigation, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: Department of Justice, Federal 

Bureau of Investigation, Criminal Justice 

Information Services Division will be 

submitting the following information 

collection request to the Office of 

Management and Budget for review and 

approval in accordance with the 

Paperwork Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for an additional 30 

day until March 30, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Extension of a currently approved 

collection. 

(2) Title of the Form/Collection: Law 

Enforcement Officers Killed and 

Assaulted Program, Analysis of Officers 

Feloniously Killed and Assaulted; and 

Law Enforcement Officers Killed and 

Assaulted Program, Analysis of Officers 

Accidentally Killed. 

(3) Agency form number, if any, and 

the applicable component of the 

Department sponsoring the collection: 

Agency form number: 1–701 and 1– 

701a. Sponsoring component: 

Department of Justice, Federal Bureau of 

Investigation, Criminal Justice 

Information Services Division. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: City, county, state, 

federal, and tribal law enforcement 

agencies. Abstract: Under Title 28, U.S. 

Code, Section 534, Acquisition, 

Preservation, and Exchange of 

Identification Records; Appointment of 

Officials, this collection requests the 

number of officers killed or assaulted 

from law enforcement agencies in order 

for the FBI Uniform Crime Reporting 

Program to serve as the national 

clearinghouse for the collection and 

dissemination of law enforcement 

officer death/assault data and to publish 

these statistics in Law Enforcement 

Officers Killed and Assaulted. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond/reply: There are approximately 

128 law enforcement agency 

respondents. This included 51 minutes 

for form 701 and 25 minutes for form 

701–a. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: There are an estimated 384.5 

hours, annual burden, associated with 

this information collection. This is 

made up of 84.5 hours for form 

completion, and 300 hours for agency 

outreach and administrative burden. 

If additional information is required 

contact: Melody Braswell, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, Suite 3E.405B, 

Washington, DC 20530. 

Dated: February 22, 2022. 

Melody Braswell, 

Department Clearance Officer, PRA, U.S. 

Department of Justice. 

[FR Doc. 2022–04089 Filed 2–25–22; 8:45 am] 

BILLING CODE 4410–02–P 

NATIONAL ARCHIVES AND RECORDS 

ADMINISTRATION 

[NARA–22–0005; NARA–2022–031] 

Records Schedules; Availability and 

Request for Comments 

AGENCY: National Archives and Records 

Administration (NARA). 

ACTION: Notice of availability of 

proposed records schedules; request for 

comments 

SUMMARY: The National Archives and 

Records Administration (NARA) 

publishes notice of certain Federal 

agency requests for records disposition 

authority (records schedules). We 

publish notice in the Federal Register 

and on regulations.gov for records 

schedules in which agencies propose to 

dispose of records they no longer need 

to conduct agency business. We invite 

public comments on such records 

schedules. 

DATES: We must receive responses on 

the schedules listed in this notice by 

April 15, 2022. 

ADDRESSES: To view a records schedule 

in this notice, or submit a comment on 

one, use the following address: https:// 

www.regulations.gov/docket/NARA-22- 

0005/document. This is a direct link to 

the schedules posted in the docket for 

this notice on regulations.gov. You may 

submit comments by the following 

method: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. On the 

website, enter either of the numbers 

cited at the top of this notice into the 

search field. This will bring you to the 

docket for this notice, in which we have 


khammond on DSKJM1Z7X2PROD with NOTICES